These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


387 related items for PubMed ID: 25393104

  • 1. Salvage combined chemotherapy with paclitaxel, ifosfamide and nedaplatin for patients with advanced germ cell tumors.
    Nakamura T, Ueda T, Oishi M, Nakanishi H, Fujihara A, Naya Y, Hongo F, Kamoi K, Okihara K, Miki T.
    Int J Urol; 2015 Mar; 22(3):288-93. PubMed ID: 25393104
    [Abstract] [Full Text] [Related]

  • 2. Salvage chemotherapy with paclitaxel, ifosfamide, and nedaplatin in patients with urothelial cancer who had received prior cisplatin-based therapy.
    Shinohara N, Harabayashi T, Suzuki S, Nagao K, Seki H, Murakumo M, Mitsuhashi K, Demura T, Nagamori S, Matsuyama H, Naito K, Nonomura K.
    Cancer Chemother Pharmacol; 2006 Sep; 58(3):402-7. PubMed ID: 16416335
    [Abstract] [Full Text] [Related]

  • 3. Salvage chemotherapy with paclitaxel, ifosfamide, and cisplatin (TIP) in relapsed or cisplatin-refractory germ cell tumors.
    Park S, Lee S, Lee J, Park SH, Park JO, Kang WK, Park YS, Lim HY.
    Onkologie; 2011 Sep; 34(8-9):416-20. PubMed ID: 21934340
    [Abstract] [Full Text] [Related]

  • 4. Paclitaxel, ifosfamide, and nedaplatin (TIN) salvage chemotherapy for patients with advanced germ cell tumors.
    Nonomura N, Oka D, Nishimura K, Nakayama M, Inoue H, Mizutani Y, Miki T, Okuyama A.
    Int J Urol; 2007 Jun; 14(6):527-31. PubMed ID: 17593098
    [Abstract] [Full Text] [Related]

  • 5. Salvage chemotherapy with docetaxel, ifosfamide and nedaplatin (DIN) for patients with advanced germ cell tumors: a preliminary report.
    Yamada S, Saito H, Ohara S, Yamashita S, Mitsuzuka K, Namiki S, Miyazato M, Kaiho Y, Ito A, Nakagawa H, Ishidoya S, Arai Y.
    Jpn J Clin Oncol; 2013 Jul; 43(7):734-9. PubMed ID: 23619987
    [Abstract] [Full Text] [Related]

  • 6. [Salvage chemotherapy with paclitaxel, ifosphamide and nedaplatin for relapsed or refractory germ cell cancer].
    Nomoto T, Mizutani Y, Mikami K, Nakamura T, Nakanishi H, Kawauchi A, Miki T.
    Nihon Hinyokika Gakkai Zasshi; 2006 May; 97(4):630-5. PubMed ID: 16768143
    [Abstract] [Full Text] [Related]

  • 7. Less nephrotoxicity of paclitaxel and ifosfamide plus nedaplatin for refractory or relapsed germ cell tumors in patients with impaired renal function.
    Shiraishi T, Nakamura T, Takamura T, Oishi M, Yamada T, Yamada Y, Ueda T, Fujihara A, Hongo F, Okihara K, Ukimura O.
    Int J Urol; 2020 Feb; 27(2):134-139. PubMed ID: 31701563
    [Abstract] [Full Text] [Related]

  • 8. Clinical significance of a second-line chemotherapy regimen with paclitaxel, ifosfamide and nedaplatin for metastatic urothelial carcinoma after failure of cisplatin-based chemotherapy.
    Kobayashi K, Matsuyama H, Shimizu K, Fujii N, Inoue R, Yamamoto Y, Matsumoto H, Nagao K.
    Jpn J Clin Oncol; 2016 Aug; 46(8):775-80. PubMed ID: 27272172
    [Abstract] [Full Text] [Related]

  • 9. Salvage chemotherapy with paclitaxel and gemcitabine plus nedaplatin (TGN) as part of multidisciplinary therapy in patients with heavily pretreated cisplatin-refractory germ cell tumors.
    Shiraishi T, Nakamura T, Mikami K, Takaha N, Kawauchi A, Miki T.
    Int J Clin Oncol; 2009 Oct; 14(5):436-41. PubMed ID: 19856053
    [Abstract] [Full Text] [Related]

  • 10. Irinotecan and nedaplatin as salvage therapy for patients with advanced germ cell tumors following intensive treatment with cisplatin-based combination chemotherapies.
    Nishikawa M, Miyake H, Fujisawa M.
    Int J Clin Oncol; 2016 Feb; 21(1):162-7. PubMed ID: 26123313
    [Abstract] [Full Text] [Related]

  • 11. Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors.
    Kondagunta GV, Bacik J, Donadio A, Bajorin D, Marion S, Sheinfeld J, Bosl GJ, Motzer RJ.
    J Clin Oncol; 2005 Sep 20; 23(27):6549-55. PubMed ID: 16170162
    [Abstract] [Full Text] [Related]

  • 12. Risk-Stratified Initial Salvage Therapy for Relapsed or Refractory Metastatic Germ Cell Tumors.
    Narayan V, Gunnarsson O, Hwang WT, Squillante CM, Nathanson KL, Stadtmauer EA, Vaughn DJ.
    Clin Genitourin Cancer; 2016 Dec 20; 14(6):524-529. PubMed ID: 27083130
    [Abstract] [Full Text] [Related]

  • 13. Paclitaxel, ifosfamide, and cisplatin second-line therapy for patients with relapsed testicular germ cell cancer.
    Motzer RJ, Sheinfeld J, Mazumdar M, Bains M, Mariani T, Bacik J, Bajorin D, Bosl GJ.
    J Clin Oncol; 2000 Jun 20; 18(12):2413-8. PubMed ID: 10856101
    [Abstract] [Full Text] [Related]

  • 14. Regional deep hyperthermia for salvage treatment of children and adolescents with refractory or recurrent non-testicular malignant germ-cell tumours: an open-label, non-randomised, single-institution, phase 2 study.
    Wessalowski R, Schneider DT, Mils O, Friemann V, Kyrillopoulou O, Schaper J, Matuschek C, Rothe K, Leuschner I, Willers R, Schönberger S, Göbel U, Calaminus G, MAKEI study group.
    Lancet Oncol; 2013 Aug 20; 14(9):843-52. PubMed ID: 23823158
    [Abstract] [Full Text] [Related]

  • 15. Paclitaxel-ifosfamide-cisplatin as salvage chemotherapy in ovarian cancer patients pretreated with platinum compounds and paclitaxel.
    Polyzos A, Kosmas C, Tsavaris N, Toufexi H, Lagadas A, Gogas H, Giannakopoulos K, Kouraklis G, Griniatsos J, Felekouras E, Tsigris C, Nikiteas N, Papadopoulos O, Giannopoulos A.
    Anticancer Res; 2007 Aug 20; 27(3B):1645-51. PubMed ID: 17595790
    [Abstract] [Full Text] [Related]

  • 16. Paclitaxel, ifosfamide, and cisplatin (TIP) as salvage and consolidation chemotherapy for advanced germ cell tumor.
    Kurobe M, Kawai K, Oikawa T, Ichioka D, Kandori S, Takaoka E, Kojima T, Joraku A, Suetomi T, Miyazaki J, Nishiyama H.
    J Cancer Res Clin Oncol; 2015 Jan 20; 141(1):127-33. PubMed ID: 25062721
    [Abstract] [Full Text] [Related]

  • 17. Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza.
    Zanetta G, Fei F, Mangioni C.
    Semin Oncol; 2000 Feb 20; 27(1 Suppl 1):23-7. PubMed ID: 10697040
    [Abstract] [Full Text] [Related]

  • 18. High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Salvage Therapy of Relapsed/Refractory Germ Cell Tumors: A Single-Center Experience.
    Yildiran Keskin GS, Erturk I, Aykan MB, Acar R, Dumludag A, Topal A, Koseoglu C, Kuzu OF, Ornek E, Karadurmus N.
    Oncol Res Treat; 2024 Feb 20; 47(6):262-272. PubMed ID: 38583428
    [Abstract] [Full Text] [Related]

  • 19. Salvage Chemotherapy With Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin for Relapsed Germ Cell Cancer.
    McKenzie HS, Mead G, Huddart R, White JD, Rustin GJS, Hennig IM, Cozens K, Cross N, Bowers M, Wheater MJ.
    Clin Genitourin Cancer; 2018 Dec 20; 16(6):458-465.e2. PubMed ID: 30115544
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.